Program: MSNonthesis Advisor: Vinayak Sant, PhD
Natalie is currently a master's student in Dr. Laura Stabile's laboratory at the University of Pittsburgh Cancer Institute. She completed her B.A. in Politics and Philosophy with a minor in Chemistry at the University of Pittsburgh in 2014. Her thesis research if focused on elucidating the role of estrogen signaling in non-small cell lung cancer and the clinical utility of estrogen blocking agents as a novel treatment strategy for lung cancer.
My research is focused on assessing strategies to target estrogen-related tumor promoting mechanisms in non-small cell lung cancer.
NJ. Rothenberger, LP. Stabile., "Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment." Cancers 2017.
JM. Siegfried, M. Farooqui, NJ. Rothenberger, S. Dacic, LP. Stabile., "Interaction between the Estrogen Receptor and Fibroblast Growth Factor Receptor Pathways in Non-Small Cell Lung Cancer." Oncotarget 2017.
AM. Egloff, LP. Stabile, MK. Gibson, J. Ohr, P. Zhou, NJ. Rothenberger, L. Wang, WE. Gooding, JL. Geiger, JT. Flaherty, JR. Grandis, JE. Bauman, "IL6 is Associated with Response to Dasatinib and Cetuximab: Phase II Clinical Trial With Mechanistic Correlatives in Cetuximab-Resistant Head and Neck Cancer." Oral Oncology 2017.